Latest News - Abbott Laboratories
Top Corporates Hub
Abbott Laboratories
Q2 Earnings: Guidance Upgrades Push These 3 Stocks Higher
24.07.2026 15:15
Companies raising guidance, particularly on the earnings front, always deserve some level of attention from investors. Recently, JNJ, GM, and ABT have all raised their outlooks.
6 Medical-Device Stocks to Buy After a Massive Selloff
24.07.2026 12:25
Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.
Medical-Device Stocks Are in the Bargain Bin. 6 to Buy.
24.07.2026 05:30
Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.
Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value?
23.07.2026 01:10
Abbott Laboratories earnings put recent stock moves in context Abbott Laboratories (ABT) is back in focus after its latest quarterly earnings, where higher year over year sales came alongside lower net income and earnings per share, sharpening attention on upcoming estimates. See our latest analysis for Abbott Laboratories. After these earnings, Abbott Laboratories' recent rally stands out, with a 7 day share price return of 12.66% and a 30 day share price return of 14.51% contrasting with a...
Unusual volume S&P500 stocks in Thursday's session
16.07.2026 17:05
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.
Exploring the top movers within the S&P500 index during today's session.
16.07.2026 16:35
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.
Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views
16.07.2026 14:32
Abbott Laboratories (ABT) lifted its full-year earnings outlook on Thursday as the healthcare firm r
Abbott, Up 14%, Strikes Three-Month High After Boosting 2026 Profit Outlook
16.07.2026 14:22
Abbott stock jumped early Thursday on better-than-expected second-quarter metrics. The company also raised its 2026 profit view.
Here's What Key Metrics Tell Us About Abbott (ABT) Q2 Earnings
16.07.2026 13:30
Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Abbott Q2 2026 earnings beat, raises full-year profit guidance
16.07.2026 13:19
The healthcare company posted adjusted earnings of $1.31 a share in the second quarter, topping Wall Street's estimate of $1.28
Abbott Laboratories (ABT) Q2 2026 Earnings Call Transcript
16.07.2026 13:16
Abbott Laboratories (ABT) Q2 2026 Earnings Call July 16, 2026 9:00 AM EDTCompany ParticipantsMichael Comilla - Vice President of Investor Relations.Robert...
Is Abbott Laboratories (ABT) Below Fair Value After Its 31% Fall?
16.07.2026 13:13
Abbott Laboratories stock has fallen sharply over the past year, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and traditional market multiples currently point to the shares trading at a discount. The share price is down about 30.7% over the past year, which has pushed investor sentiment lower while opening a potential valuation gap. Progress in colorectal cancer diagnostics and partnerships in continuous glucose monitoring can support long term cash...
Chip Selloff Drags Nasdaq 100, Gold Sinks Below $4,000: Stock Market Today
16.07.2026 13:06
A semiconductor selloff sank the Nasdaq 100 more than 1% while UnitedHealth's blowout quarter lifted the Dow.
Abbott Laboratories (NYSE:ABT) Surprises With Q2 CY2026 Sales
16.07.2026 13:00
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 13% year on year to $12.59 billion. Its non-GAAP profit of $1.31 per share was 2.6% above analysts’ consensus estimates.
Abbott Bounds Higher After Hiking 2026 Profit View On Second-Quarter Beat
16.07.2026 12:55
Abbott stock jumped early Thursday on better-than-expected second-quarter metrics. The company also raised its 2026 profit view.
Abbott raises 2026 earnings outlook after second-quarter results beat expectations (ABT)
16.07.2026 12:43
Abbott Laboratories (NYSE:ABT) delivered stronger-than-expected second-quarter results and increased its full-year earnings guidance, sending its shares about 2. 5% higher in premarket trading.
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
16.07.2026 12:40
Abbott (ABT) delivered earnings and revenue surprises of +2.34% and +0.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Abbott Laboratories NYSE:ABT Rises on In-Line Q2 and Raised Guidance
16.07.2026 12:20
Abbott Labs Q2 2026 earnings met expectations, slightly beating EPS estimates. The company raised its full-year guidance, boosting investor confidence and driving pre-market gains over 3%.
Abbott beats second-quarter estimates, raises 2026 guidance
16.07.2026 12:10
Investing.com -- Abbott (NYSE:ABT) shares are trading higher premarket on Thursday after the company reported second-quarter earnings, topping consensus expectations and raising its full-year earnings guidance.
Stocks making the biggest moves midday: Manpower, Abbott, UnitedHealth, TSMC & more
16.07.2026 12:03
These are the stocks posting the largest moves in midday trading.